(Q40385527)

20 September 2017

1 reference

title

Active specific immunotherapy against adenocarcinomas (English)

1 reference

20 September 2017

1 reference

1 reference

MacLean GD

1

1 reference

20 September 2017

Reddish MA

2

1 reference

20 September 2017

Bowen-Yacyshyn MB

3

1 reference

20 September 2017

Poppema S

4

1 reference

20 September 2017

Longenecker BM

5

1 reference

20 September 2017

1 January 1994

1 reference

20 September 2017

1 reference

20 September 2017

12

1 reference

20 September 2017

1

1 reference

20 September 2017

46-56

1 reference

Biomodulators in cancer treatment

20 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Class II (DR) antigen expression on CD8+ lymphocyte subsets in acquired immune deficiency syndrome (AIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

The CD8+ Leu-7+ subset of T cells in Crohn's disease: distinction between cytotoxic and covert suppressor functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

The increase of non-MHC-restricted cytotoxic cells (gamma/delta-TCR-bearing T cells or NK cells) and the abnormal differentiation of B cells in Wiskott-Aldrich syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

A new approach in specific, active immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Viral oncolysates in patients with advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Effect of virus-modified tumor cell extracts, autologous mononuclear cell infusions and interleukin-2 on oncolytic activity of effector cells of patients with advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Postoperative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine. First clinical results with tumor-cell vaccines modified with live but avirulent Newcastle disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Adjuvant specific active lung cancer immunotherapy trials. Tumor-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Immunosuppressive therapy. The relation between clinical response and immunologic competence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Active-specific immunotherapy for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Interleukin-1 as an adjuvant for tumor vaccines increases survival in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

Immunotherapy of Metastases Enhances Subsequent Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909409021392

10.3109/07357909409021392

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference